01—Abstract
Summary
Summary of the 8-K filed April 30, 2024. Cited figures are marked; the original filing is the authoritative source.
ADM reported first-quarter 2024 results that fell sharply year over year but were in line with management's expectations for a challenging market.
GAAP EPS was $1.42a, down 33% from $2.12, and adjusted EPS was $1.46, down 30% from $2.09. Adjusted segment operating profit was $1,317 million, down 24%, driven primarily by Ag Services & Oilseeds (down 29%), where lower crush and origination margins, a stabilization of trade flows that reduced Global Trade and risk management gains, and a sharp drop in mark-to-market timing benefits weighed on results. Nutrition (down 39%) and Carbohydrate Solutions (down 11%) also declined, while the Other segment rose 25%.
Management affirmed full-year 2024 adjusted EPS guidance of $5.25 to $6.25b, a wide range that signals continued uncertainty. Cash flow and balance sheet data show a mixed picture. Operating cash flow turned positive at $700 million versus a $1,610 million outflow a year earlier, largely because of smaller working capital build.
However, the company spent $915 millionc on acquisitions, $1,327 million on share repurchases (including the accelerated share repurchase program), and $257 million on dividends, funded in part by a $1,619 million increase in net borrowings. Short-term debt, long-term debt, and shareholders' equity all trended in ways that warrant monitoring, and cash fell to $830 million. Trailing four-quarter adjusted ROIC was 11.2%, and adjusted EBITDA was $5.74 billion.
For investors, the key questions are whether margins in crush and origination stabilize as management expects, whether the Nutrition segment recovers from the Decatur East downtime and normalizing texturants market, and whether the company can deliver on guidance while funding both acquisitions and substantial buybacks with rising debt. The filing itself is a routine Item 2.02 disclosure furnishing the earnings press release as Exhibit 99.1, and the non-GAAP measures are reconciled within that release.
02—Key points
Key Highlights
- GAAP EPS of $1.42 fell 33% year over year; adjusted EPS of $1.46 fell 30% from $2.09, reflecting lower crush and origination margins and smaller mark-to-market timing benefits.
- Adjusted segment operating profit of $1,317 million declined 24%, with Ag Services & Oilseeds down 29% to $864 million, making it the primary driver of the decline.
- Nutrition segment operating profit fell 39% to $84 million due to unplanned downtime at Decatur East and a normalizing texturants market, though Animal Nutrition improved and management cited sequential quarterly improvement.
- Full-year 2024 adjusted EPS guidance of $5.25 to $6.25 was affirmed, a wide range that reflects significant uncertainty in market conditions.
- Operating cash flow was $700 million, a sharp improvement from a $1,610 million outflow a year earlier, but $915 million went to acquisitions and $1,327 million to share repurchases.
- Net borrowings rose $1,619 million during the quarter, and cash and equivalents declined to $830 million, increasing reliance on credit lines to fund shareholder returns and acquisitions.
- Trailing four-quarter adjusted ROIC was 11.2%, and adjusted EBITDA was $5.74 billion over the same period.
03—Questions
Frequently Asked Questions
Why did ADM's earnings decline so significantly in Q1 2024?
The decline was driven mainly by lower pricing and execution margins, which reduced EPS by $1.00 versus the prior year. Crush and origination margins weakened as imports of used cooking oil and expected large South American soybean supplies pressured North American crush margins. Trade flows also stabilized, which reduced Global Trade and risk management gains, and mark-to-market timing benefits fell by $0.38 per share. Lower energy costs and higher processed volumes partially offset these headwinds.
Is ADM still expecting to meet its full-year 2024 earnings guidance?
Yes. ADM affirmed its full-year 2024 adjusted EPS guidance of $5.25 to $6.25. The company did not provide a GAAP EPS forecast, citing the unreasonable efforts exemption because it cannot reliably predict impairment, restructuring, acquisition-related, and regulatory or legal charges. The range is wide, which indicates meaningful uncertainty about the remainder of the year.
What is happening in the Nutrition segment?
Nutrition operating profit fell 39% to $84 million. Human Nutrition dropped 45% to $76 million because of unplanned downtime at the Decatur East facility and a normalizing texturants market. Animal Nutrition earned $8 million, up from breakeven, as cost optimization and lower input costs helped. Management said the segment delivered sequential quarterly improvement in operating profit.
How is ADM using its cash, and is the capital allocation sustainable?
In Q1 2024, ADM spent $915 million on acquisitions, $1,327 million on share repurchases (including an accelerated share repurchase program), and $257 million on dividends. These were funded by operating cash flow of $700 million and a $1,619 million increase in net borrowings. Because the buybacks and acquisitions exceeded operating cash flow and were debt-financed, investors may want to watch leverage and whether earnings recover enough to support this level of returns.
Are there any one-time charges or non-GAAP adjustments investors should understand?
The GAAP results included roughly $6 million in impairment and restructuring charges at the segment level, about $0.01 per share, and $12 million in corporate restructuring charges. Including other items, total impairment and restructuring charges were approximately $0.03 per share in the adjusted EPS reconciliation. Adjusted EPS excludes these items, and the difference between GAAP ($1.42) and adjusted ($1.46) EPS is small this quarter, so the adjustments do not materially change the investment picture.
04—Continue